Chronic respiratory distress and snoring in pets and livestock present a complex challenge for B2B distributors and veterinary brands. Sourcing effective, safe, and custom-formulated treatments requires more than just a standard supplier; it demands an integrated pharmaceutical partner. Without precise formulations—such as targeted peptides and specific antigens—treatment efficacy drops, directly impacting animal welfare and brand reputation.
Since 2008, Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. has bridged the gap between complex veterinary needs and reliable manufacturing. Operating from a sprawling 21,000 square meter facility in the Xinle City East Industrial Park, the enterprise specializes in high-tech veterinary drug preparations. Whether dealing with pet anti-parasitics or advanced respiratory interventions, having a dedicated partner ensures your formulations are potent and compliant.
By leveraging over 100 varieties of production lines—spanning oral solutions, powders, and mixed feed additives—brands can confidently address niche market demands. The facility successfully passed the stringent new veterinary drug GMP acceptance by the Ministry of Agriculture in 2022, guaranteeing that every batch meets elite global quality thresholds. This level of infrastructure removes the typical bottlenecks associated with scaling bespoke animal health products.
To manufacture highly effective veterinary medications and specialized respiratory supplements, the underlying manufacturing infrastructure must be uncompromising. A superior production environment integrates strict quality control mechanisms with advanced active pharmaceutical ingredient (API) handling, ensuring maximum bioavailability and shelf stability.
We benchmark our capabilities against the highest international pharmaceutical standards. Below is an overview of the technical metrics that define our operational excellence:
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Facility Certification | Determines regulatory compliance and base safety for all medical formulations. | Ministry of Agriculture GMP Certified (Passed 2022) | Guarantees zero-contamination environments, essential for specific antigens and peptides. |
| Production Versatility | Allows brands to adapt delivery methods based on animal species and dosage requirements. | 100+ varieties including powder, premix, oral solution, and liquid feed additives | Rapid prototyping and scalable manufacturing for customized respiratory and anti-snoring treatments. |
| Active Ingredient Integrity | Ensures the therapeutic efficacy of complex biologics and raw materials. | Integration of advanced probiotics (Bacillus Coagulans SNZ 1969) and peptides | Maximizes gastrointestinal and systemic absorption for faster therapeutic response in animals. |
| Global Accessibility | Facilitates seamless international trade, documentation, and localized support. | Multi-language infrastructure (Arabic, French, German, Russian, Spanish) | Accelerates market entry across diverse geographical regions with tailored compliance. |
Strategic procurement in the veterinary pharmaceutical sector is fundamentally tied to long-term financial performance. Partnering with a comprehensive R&D, production, and sales integration model dramatically reduces time-to-market. By consolidating your supply chain into a single, highly capable 21,000 sqm hub, your brand eliminates the hidden costs of multi-vendor management and quality inconsistencies.
Financial yields in the animal health market are driven by product efficacy and supply reliability. Our continuous advancements—highlighted by recent 2026 R&D publications regarding specific Bacillus Coagulans applications and advanced pharmaceutical guides—ensure our partners remain at the forefront of market innovation. This visionary approach transforms raw materials into high-margin, market-ready veterinary solutions.
Related products
Top Selling Products
